Johns Hopkins Health System
Baltimore, Maryland, 21287, United States
NCT Number: NCT05412433
Hybrid Type II effectiveness-implementation trial to investigate whether electronic medical and sexual history data collection with HIV risk categorization/scoring will increase pre-exposure prophylaxis (PrEP) uptake among cis-gender women attending routine well-woman gynecologic preventative visits.
This study is active but is not currently recruiting participants.
15 year–65 year
Female
Interventional
Not applicable
Baltimore, Maryland, 21287, United States
Forty-two Obgyn providers will be randomized into 1 of three arms. Patients of enrolled providers who attend an ObGyn clinic for any preventative visit will complete an electronic history form (eHxForm) before clinic through a message sent through the patient portal (MyChart), email, or secure text messaging. The sexual history questions will be scored and categorized into 3 categories. Patients with a low score (0-3) will receive an electronic message offering a laboratory HIV test per USPSTF guidelines. If she accepts, then an automated Epic order will be placed for the provider to sign during the office visit.
Patients with a medium/high score (4-10) will be assigned a study arm based on their provider's group (arm 1: control, arm 2: patient will view score and a PrEP video, arm 3: procedures in arm 2 PLUS providers will receive an electronic health record alert that the patient may have HIV risk factors. This will occur automatically via programming integrated into the electronic health record. The primary outcome is PrEP uptake. The implementation strategy will be evaluated using the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Electronic data collection with scoring, patient awareness of HIV risk score, patient viewing of PrEP animations
Electronic data collection with scoring, patient awareness of HIV risk score, patient viewing of PrEP animations, provider electronic health records (EHR) alerts
Standard of care
Time frame: 4 weeks
Number of PrEP prescriptions written for each patient up to 4 weeks after office visit.
Time frame: Approximately 5 years
Incremental cost-effectiveness ratios
Time frame: Approximately 5 years
Return on investment (intervention benefits, avoided direct medical costs, and incremental implementation costs)
Time frame: Approximately 5 years
Total budget to finance each intervention strategy (intervention and implementation costs)
Time frame: 6 months
Adoption of Electronic History Form as assessed by the proportion of consecutive eligible patients in each clinic who completed the eHxForm.
Johns Hopkins University
Other
Acronym: CHIPPER
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06638892
HIV Prevention, PreP
Durham, North Carolina, United States
View Trial DetailsNCT06703060
HIV Prevention, Intimate Partner Violence (IPV)
Baltimore, Maryland, United States
View Trial DetailsNCT07231640
HIV, HIV Prevention
Birmingham, Alabama, United States
View Trial DetailsNCT05644834
HIV Prevention, Mobile Health
Chapel Hill, North Carolina, United States
View Trial Details